`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ALERE INC.
`Petitioner
`
`v.
`
`REMBRANDT DIAGNOSTICS, LP
`Patent Owner
`
`
`Case No. IPR2016-01498
`
`Patent No. 8,623,291
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S MOTION FOR PRO HAC VICE ADMISSION OF LANA S.
`SHIFERMAN UNDER 37 C.F.R. § 42.10(c)
`
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case No. IPR2016-01498
`
`Alere Inc. (“Petitioner”) respectfully requests the pro hac vice admission of
`
`Lana S. Shiferman in this proceeding, IPR2016-01498, concerning U.S. Patent No.
`
`8,623,291 (“the ‘291 patent”), pursuant to 37 C.F.R. § 42.10(c).
`
`I.
`
`THE REQUEST IS TIMELY
`
`As stated in the Patent Trial and Appeal Board’s (“Board”) August 15, 2016
`
`Notice of Filing Date Accorded to Petition And Time For Filing Patent Owner
`
`Preliminary Response, any motion for pro hac vice admission must be filed in
`
`accordance with the guidance specified in Case IPR2013-00639 (Paper 7) (“PHV
`
`Admission Order”). According to that guidance, pro hac vice motions can be filed
`
`no sooner than (21) days after service of the Petition. This pro hac vice motion is
`
`filed more than 21 days after the service of the Petition and is therefore timely.
`
`II.
`
`STATEMENT OF FACTS
`
`As required by the PHV Admission Order, the following statement of facts
`
`show that there is good cause for the Board to recognize Ms. Shiferman pro hac
`
`vice. An affidavit by Ms. Shiferman containing the required statements and
`
`information is submitted herewith. (Ex. 1014).
`
`1. Douglas J. Kline, lead counsel for Petitioner Alere Inc. in this
`
`proceedings, is a registered practitioner holding Registration No. 35,574.
`
`2. Ms. Shiferman is a partner with Goodwin Procter LLP.
`
`
`
`
`1
`
`
`
`Case No. IPR2016-01498
`
`3. Ms. Shiferman has an established familiarity with the subject matter at
`
`issue in this proceeding. Ms. Shiferman has represented and continues to represent
`
`petitioner Alere Inc. and its subsidiaries Alere Toxicology Services, Inc., America
`
`Biotech, Inc., Ameditech, Inc., Innovacon, Inc., Instant Technologies, Inc., Instant
`
`Tech Subsidiary Acquisition Inc. d/b/a US Diagnostics, and Branan Medical Corp.
`
`in co-pending litigation in the Southern District of California, captioned
`
`Rembrandt Diagnostics, LP v. Alere Inc., et al., No. 3:16-cv-698-CAB-NLS (“the
`
`district court litigation”) since shortly after it was filed on March 23, 2016.
`
`Among other things, the district court litigation asserts infringement of the same
`
`patent at issue here, U.S. Patent No. 8,623,291.
`
`5. Ms. Shiferman represents that she has reviewed and analyzed the
`
`patent at issue in this proceeding, the Petition and accompanying exhibits filed in
`
`this proceeding, and all other papers associated with this proceeding. Moreover,
`
`she represents that in the district court litigation, she developed invalidity, non-
`
`infringement, and claim construction positions concerning the patent at issue here.
`
`She therefore has extensive knowledge of this patent and of the cited prior art.
`
`6. Ms. Shiferman is an experienced litigation attorney. Ms. Shiferman
`
`has been litigating patent cases for over fifteen years. Ms. Shiferman has been
`
`practicing law since 1999 and has extensive experience litigating patent
`
`infringement cases in many different courts across the United States.
`
`
`
`
`2
`
`
`
`Case No. IPR2016-01498
`
`7. Ms. Shiferman’s experience in patent litigation matters includes
`
`patent jury trials, presentation of non-expert and expert-testimony, arguing
`
`Markman hearings, patent summary judgment proceedings, and other patent-
`
`related hearings and preparation of pleadings concerning, inter alia, patent validity
`
`and infringement issues. Ms. Shiferman has also represented clients in appeals
`
`before the Court of Appeals for the Federal Circuit.
`
`8. Ms. Shiferman represented petitioner Alere Inc. and/or its affiliates in
`
`many patent litigation matters since 2003, including:
`
`Name
`Alere Inc., et. al. v. Church & Dwight
`Co., Inc.
`Inverness Medical Innovations, Inc. et al.
`v. Orasure Technologies, Inc.
`Abbott Laboratories et al v. Church
`& Dwight, Inc.
`Inverness Medical, et al v.
`Quidel Corporation
`Quidel Corporation v. Inverness
`Medical, et al.
`Inverness Medical Switzerland GmbH
`et al v. Acon Laboratories, Inc.
`Inverness Medical, et al v.
`Acon Laboratories, Inc.
`Inverness Medical SW, et al. v.
`Pfizer Inc., et al.
`Inverness Medical, et al v. Pfizer, Inc.,
`et al.
`
`
`
`
`
`
`3
`
`Filed
`January 8,
`2010
`
`April 15, 2008
`
`June 18, 2007
`
`MAD
`
`NJD
`
`ILND
`
`Number District
`1-10-cv-
`10027
`3-08-cv-
`01856
`1-07-cv-
`03428
`3-04-cv-
`00489
`3-04-cv-
`00378
`1-03-cv-
`11323
`1-02-cv-
`12303
`2-02-cv-
`01029
`2-01-cv-
`05516
`
`CASD March 9, 2004
`CASD February 20,
`2004
`
`MAD
`July 15, 2003
`MAD November 26,
`2002
`
`NJD
`
`NJD
`
`March 7, 2002
`
`November 29,
`2001
`
`
`
`Case No. IPR2016-01498
`
`9. Ms. Shiferman is a member in good standing of the Bar of the State of
`
`Massachusetts and admitted to practice before the U.S. District Court for the
`
`District of Columbia, the U.S. District Court for the District of Massachusetts, the
`
`U.S. District Court for the Eastern District of Texas, U.S. District Court for the
`
`District of Connecticut, the U.S. District Court for the District of New Jersey, U.S.
`
`District Court for the Northern District of Illinois, the U.S. Court of Appeals for
`
`the First, Second and Federal Circuits, and the International Trade Commission.
`
`10. Ms. Shiferman has never been suspended or disbarred from practice
`
`before any court or administrative body.
`
`11. No application of Ms. Shiferman for admission to practice before any
`
`court or administrative body has ever been denied.
`
`12. No sanctions or contempt citations have ever been imposed against
`
`Ms. Shiferman by any court or administrative body.
`
`13. Ms. Shiferman represents that she has read and will comply with the
`
`Office Patent Trial Practice Guide and the Board’s Rules of Practice for Trials set
`
`forth in part 42 of 37 C.F.R.
`
`14. Ms. Shiferman represents that she understands that she will be subject
`
`to the U.S.P.T.O. Code of Professional Conduct set forth in 37 C.P.R. §§ 10.101 et
`
`seq. and disciplinary jurisdiction under 37 C.P.R. §§ 11.19(a).
`
`
`
`
`4
`
`
`
`Case No. IPR2016-01498
`
`15. Ms. Shiferman is also applying for pro hac vice admission in Case
`
`IPR2016-01502, in a concurrently filed motion, which involved a patent related to
`
`the patent at issue in the instant proceeding. Ms. Shiferman has not applied for pro
`
`hac vice admission in any other proceedings before the Office in the last three
`
`years.
`
`16. This motion was filed no sooner than 21 days after service of the
`
`Petition in this proceeding, which occurred on July 27, 2016.
`
`III. CONCLUSION
`For the foregoing reasons, Petitioner respectfully requests that the Board
`
`admit Lana S. Shiferman pro hac vice in this proceeding.
`
`
`
`Dated: October 25, 2016
`
`Respectfully submitted,
`
`
`
`/ Douglas J. Kline /
`(Reg. No. 35,574)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02110
`Tel: 617-523-1000
`Fax: 617-523-1231
`Email: dkline@goodwinlaw.com
`
`Counsel for Petitioner Alere Inc.
`
`
`
`
`5
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing document captioned
`
`PETITIONER’S MOTION FOR PRO HAC VICE ADMISSION OF LANA S.
`
`SHIFERMAN UNDER 37 C.F.R. § 42.10(c) was served electronically via e-mail
`
`on this 25th day of October, 2016, as follows:
`
`Joseph F. Jennings (Reg. No. 40,664)
`Jared C. Bunker (Reg. No. 58,474)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, Fourteenth Floor
`Irvine, CA 92614
`Tel: 949-760-0404
`Fax: 949-760-9502
`Email: BoxRembrandt-LP2@knobbe.com
`
`Counsel for Rembrandt Diagnostics, LP
`
`/Douglas J. Kline/
`Douglas J. Kline
`Registration No. 35,574
`GOODWIN PROCTER LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: October 25, 2016